secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001193125-23-155430
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE raises $4.5M via underwritten offering of Series H preferred stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$4.5M from 175,000 units at $26/unit; each unit includes one share Series H preferred ($50 liquidation pref, 48% OID) and warrant to buy 0.5 preferred share.
- Series H preferred converts to common at $0.1398/share; carries 20% PIK dividend (one-time after one year); 2-year term with mandatory redemption at $50 stated value.
- Warrants exercisable at $13 per warrant (for 0.5 preferred share), immediately exercisable, 2-year term.
- Net proceeds for working capital and general corporate purposes; offering closed May 26, 2023.
- Lake Street Capital Markets and Maxim Group acted as joint bookrunners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000119312523155430/0001193125-23-155430-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000119312523155430/d469757d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-155430

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer